GSK to appeal against French vaccines ruling
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline France says it will appeal against a civil tribunal's award of almost €400,000 in damages to a woman who claimed that vaccination with GSK's Engerix B (hepatitis B) in the 1990s caused her multiple sclerosis (scripnews.com, June 29th, 2009).